EUR J CANCER 2020 10.1016/j.ejca.2020.03.029
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
Lee1, J; La Choi, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

CLIN LUNG CANCER 2020 10.1016/j.cllc.2019.11.006
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests
Byeon1, S; Lee, B; Park, WY; Choi, YL; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH

NAT COMMUN 2020 10.1038/s41467-020-16164-1
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Kim1, N; Kim, HK; Lee, K; Hong, Y; Cho, JH; Choi, JW; Lee, J; Suh, YL; Ku, BM; Eum, HH; Choi, S; Choi, YL; Joung, JG; Park, WY; Jung, HA; Sun, JM; Lee, SN; Ahn, JS; Park, K; Ahn, MJ; Lee, HO

IN VIVO 2020 10.21873/invivo.11920
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
Hur1, JY; Ku, BM; Shim, JH; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

Cancer Med 2020 10.1002/cam4.2868
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence
Byeon1, S; Cho, JH; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

CANCER RES TREAT 2020 10.4143/crt.2019.186
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea
Lee1, K; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahm, MJ

BMC OPHTHALMOL 2020 10.1186/s12886-019-1285-9
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors
Shin1, E; Lim, DH; Han, JS; Nam, D; Park, K; Ahn, MJ; Kang, WK; Lee, JY; Ahn, JS; Lee, SH; Sun, JM; Jung, HA; Chung, TY

Cancer Med, 2019.09, 8(12):5431-5437
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.
Woo Kyun Bae1, Hyo Jin Lee, Se Hoon Park, Jung Hoon Kim, Hee Jun Kim, Chi Hoon Maeng, Inkeun Park, Byeong Seok Sohn, Jung A. Kim, Kyung Hee Lee, Do Hyoung Lim, Hyun Chang, Sung Min Kim, Ho Young Kim, Hunho Song, Seungtaek Lim, Jae Ho Byun, Hyun Ae Jung

INT J CANCER 2019 10.1002/ijc.32235
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Shin1, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH

Cancer Med 2019 10.1002/cam4.2446
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03
Bae1, WK; Lee, HJ; Park, SH; Kim, JH; Kim, HJ; Maeng, CH; Park, I; Sohn, BS; Kim, JA; Lee, KH; Lim, D; Chang, H; Kim, SM; Kim, HY; Song, H; Lim, S; Byun, JH; Jung, HA

J CANCER RES CLIN 2019 10.1007/s00432-019-02889-0
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma
Cho1, JH; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

LUNG CANCER 2019 10.1016/j.lungcan.2019.01.012
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer
Lee1, K; Kim, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Choi, YL; Sun, JM

Ann Lab Med, 2018.05, 38(3):196-203
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
Hyun Ae Jung1, Mi-Ae Jang, Sun-Hee Kim, Kihyun Kim

LUNG CANCER 2018 10.1016/j.lungcan.2018.06.009
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
Lee1, J; Jung, HA; Kim, Y; Choi, S; Han, J; Choi, YL; Lee, SH; Ahn, JS; Park, K; Sun, JM

ANN LAB MED 2018 10.3343/alm.2018.38.3.196
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
Jung1, HA; Jang, MA; Kim, K; Kim, SH

Cancer Res Treat, 2015.01, 47(1):72-7
Changes in the Mean Corpuscular Volume after Capecitabine Treatment Is Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer
Hyun Ae Jung1, Hyun-Jun Kim,Chi Hoon Maeng, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Tumour Biol. 2015.02, 36(2):1073-9
Prognostic relevance of biological subtype overriding TNM staging in breast cancer: discordance between stage and biology
Hyun Ae Jung1, Yeon Hee Park, Moonjin Kim, Sungmin Kim, Won Jin Chang, Moon Ki Choi, Jung Yong Hong, Seok Won Kim, Won Ho Kil, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn and Young-Hyuck Im

Oncotarget. 2015.06.30, 6(18):16653-62.
Platelet response at second cycle of decitabine can predict response and survival for myelodysplastic syndromes (MDS) patients
Hyun Ae Jung1, Moonjin Kim, Sungmin Kim, Chi Hoon Maeng, Chul Won Jung, and Jun Ho Jang

Anticancer Res, 2014.02, 34(2):1037-45
Prognostic Factor Analysis in Core-Binding Factor-positive Acute Myeloid Leukemia
Hyun Ae Jung1, Chi Hoon Maeng, Silvia Park, Seok Jin Kim, Kihyun Kim, Jun Ho Jang and Chul Won Jung

Korean J Intern Med, 2014.05, 29(3):398-401
Infective Endocarditis due to Extended Spectrum Beta-Lactamase (ESBL) producing Klebsiella Pneumonia
Hyun-Ae Jung1, Young Eun Ha, Damin Kim, Jihyun Park , Cheol-In Kang , Doo Ryeon Chung ,Seung Woo Park , Ki Ik Sung , Jae-Hoon Song and Kyong Ran Peck

J Transl Med, 2014.10.25, 12:299
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Hyun Ae Jung1, Bo Mi Ku, Jong-Mu Sun, Young Hyeh Ko, Han-Sin Jeong, Young-Ik Son, Chung-Hwan Baek, Keunchil Park and Myung-Ju Ahn

Chemotherapy. 2014, 60(2):73-80
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer
Hyun Ae Jung1, Jong-Mu Sun, Se Hoon Park, Ghee Young Kwon and Ho Yeong Lim

Leuk Lymphoma. 2014.10, 55(10):2395-7
Spinal cord compression in multiple myeloma: a single center experience
Hyun Ae Jung1, Soo Hee Cho, Seok Jin Kim, Jun Ho Jang, Won Seog Kim , Chul Won Jung , Kihyun Kim

Cancer Res Treat, 2013. 12, 45(4):285-94
Nomogram to Predict Treatment Outcome of Fluoropyrimidine/Platinum-Based Chemotherapy in Metastatic Esophageal Squamous
Hyun Ae Jung1, Antoine Adenis, Jeeyun Lee, Se Hoon Park, Chi Hoon Maeng, Silvia Park, Hee Kyung Ahn, Young Mog Shim, Nicolas Penel, Young-Hyuck Im

Journal of Hematology & Oncology, 2013. 11, 6:86
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
Hyun Ae Jung1, Seok Jin Kim, Shih-Sung Chuang, Huangming Hong, Cheng-Cheng Guo, Junning Cao, Xiao-Nan Hong, Ritsuro Suzuki, Hye Jin Kang, Jong Ho Won, Wee-Joo Chng, Yok-Lam Kwong, Cheolwon Suh, Yu-Qin Song, Jun Zhu, Kevin Tay, Soon Thye Lim, Junji Suzumiya, Tong Yu Lin and Won Seog Kim

Ann Hematol, 2012.11, 91(11):1747 - 1756
Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
Hyun Ae Jung 1, Silvia Park, Jin Hyun Cho, Seonwoo Kim ,Young Hyeh Ko ,Seok Jin Kim ,Won Seog Kim